PMA device
Ascension MCP
Smith & Nephew, Inc. · Finger Semi-Constrained Pyrolytic Carbon Uncemented Prosthesis (NEG, Class III) · First FDA decision Nov 19, 2001, newest Mar 5, 2019Hand and wrist conditions
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
7
PMA pathway
Device trials
1
Naming "Ascension MCP"
MAUDE reports
0
Brand "Ascension MCP", since 2015
PubMed studies
0
Mentioning "Ascension MCP"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Ascension MCP
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 7 decisions filed under this name.
- Ascension MCPPMA supplement
P000057-S011 · Decided Mar 5, 2019 · 146 days after receipt · Normal 180 Day Track No User Fee
Device type: Finger semi-constrained pyrolytic carbon uncemented prosthesis (NEG) · Orthopedic Surgery
- Ascension MCPPMA supplement
P000057-S010 · Decided Jun 29, 2018 · 269 days after receipt · Normal 180 Day Track No User Fee
Device type: Finger semi-constrained pyrolytic carbon uncemented prosthesis (NEG) · Orthopedic Surgery
- ASCENSION MCP FINGER IMPLANTPMA supplement
P000057-S008 · Decided Sep 10, 2018 · 1,440 days after receipt · Normal 180 Day Track No User Fee
Device type: Finger semi-constrained pyrolytic carbon uncemented prosthesis (NEG) · Orthopedic Surgery
3 more FDA decisions with a free account
Older decisions: P000057
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Ascension MCP", any status and sponsor, newest update first.
Smith & Nephew, Inc.Public (SNN)
NCT02408471 · 97 participants · Start Jun 2002 · Primary completion Jan 2015
Device: Ascension® MCP Finger Implant · For: Rheumatoid Arthritis; Systemic Lupus Erythematosus; Osteoarthritis and 1 more
Sites: Tucson, Arizona; Bloomington, Indiana; Carmel, Indiana · 9 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Ascension MCP", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NEG
56 reports: 26 malfunction, 30 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0550-03 · Started Oct 31, 2002 · Posted by FDA Feb 8, 2003
Reason given: Literature approved for international distribution only was distributed domestically.
Cause as FDA categorized it: Other
Published research
The most relevant PubMed records for "Ascension MCP"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.